Legis Daily

Medical Marijuana Research Act

USA116th CongressHR-3797| House 
| Updated: 12/18/2020
Earl Blumenauer

Earl Blumenauer

Democratic Representative

Oregon

Cosponsors (21)
Chris Stewart (Republican)Barbara Lee (Democratic)Raúl M. Grijalva (Democratic)Lisa Blunt Rochester (Democratic)Andy Harris (Republican)J. Luis Correa (Democratic)Dina Titus (Democratic)John R. Curtis (Republican)Greg Walden (Republican)Debbie Dingell (Democratic)Earl L. "Buddy" Carter (Republican)Rob Bishop (Republican)Lloyd Smucker (Republican)H. Morgan Griffith (Republican)Eleanor Holmes Norton (Democratic)Sean Casten (Democratic)Vicky Hartzler (Republican)Matt Gaetz (Republican)Zoe Lofgren (Democratic)Cathy McMorris Rodgers (Republican)Bryan Steil (Republican)

Crime and Federal Government Surveillance Subcommittee, Judiciary Committee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Medical Marijuana Research Act This bill establishes a new, separate registration process to facilitate medical marijuana research. Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research. Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and implement a specialized process for supplying marijuana products available through state-authorized marijuana programs to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 17, 2019
Introduced in House
Jul 17, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 18, 2019
Referred to the Subcommittee on Health.
Aug 6, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Sep 9, 2020
Committee Consideration and Mark-up Session Held.
Sep 9, 2020
Ordered to be Reported (Amended) by Voice Vote.
Dec 7, 2020
Placed on the Union Calendar, Calendar No. 508.
Dec 7, 2020
Committee on the Judiciary discharged.
Dec 7, 2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-619, Part I.
Dec 9, 2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Dec 9, 2020
Considered under suspension of the rules. (consideration: CR H7076-7083)
Dec 9, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 3797.
Dec 9, 2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Dec 9, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7076-7078)
Dec 9, 2020
Motion to reconsider laid on the table Agreed to without objection.
Dec 10, 2020
Received in the Senate.
Dec 18, 2020
Read twice and referred to the Committee on the Judiciary.
  • July 17, 2019
    Introduced in House
  • July 17, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • July 18, 2019
    Referred to the Subcommittee on Health.
  • August 6, 2019
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • September 9, 2020
    Committee Consideration and Mark-up Session Held.
  • September 9, 2020
    Ordered to be Reported (Amended) by Voice Vote.
  • December 7, 2020
    Placed on the Union Calendar, Calendar No. 508.
  • December 7, 2020
    Committee on the Judiciary discharged.
  • December 7, 2020
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-619, Part I.
  • December 9, 2020
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.
  • December 9, 2020
    Considered under suspension of the rules. (consideration: CR H7076-7083)
  • December 9, 2020
    DEBATE - The House proceeded with forty minutes of debate on H.R. 3797.
  • December 9, 2020
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
  • December 9, 2020
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7076-7078)
  • December 9, 2020
    Motion to reconsider laid on the table Agreed to without objection.
  • December 10, 2020
    Received in the Senate.
  • December 18, 2020
    Read twice and referred to the Committee on the Judiciary.

Health

Related Bills

  • HR 116-1119: Responsibly Addressing the Marijuana Policy Gap Act of 2019
  • S 116-421: Responsibly Addressing the Marijuana Policy Gap Act of 2019
Administrative law and regulatory proceduresAlternative treatmentsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesFood and Drug Administration (FDA)Health personnelLicensing and registrationsMedical researchResearch administration and funding

Medical Marijuana Research Act

USA116th CongressHR-3797| House 
| Updated: 12/18/2020
Medical Marijuana Research Act This bill establishes a new, separate registration process to facilitate medical marijuana research. Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research. Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and implement a specialized process for supplying marijuana products available through state-authorized marijuana programs to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 17, 2019
Introduced in House
Jul 17, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 18, 2019
Referred to the Subcommittee on Health.
Aug 6, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Sep 9, 2020
Committee Consideration and Mark-up Session Held.
Sep 9, 2020
Ordered to be Reported (Amended) by Voice Vote.
Dec 7, 2020
Placed on the Union Calendar, Calendar No. 508.
Dec 7, 2020
Committee on the Judiciary discharged.
Dec 7, 2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-619, Part I.
Dec 9, 2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Dec 9, 2020
Considered under suspension of the rules. (consideration: CR H7076-7083)
Dec 9, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 3797.
Dec 9, 2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Dec 9, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7076-7078)
Dec 9, 2020
Motion to reconsider laid on the table Agreed to without objection.
Dec 10, 2020
Received in the Senate.
Dec 18, 2020
Read twice and referred to the Committee on the Judiciary.
  • July 17, 2019
    Introduced in House
  • July 17, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • July 18, 2019
    Referred to the Subcommittee on Health.
  • August 6, 2019
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • September 9, 2020
    Committee Consideration and Mark-up Session Held.
  • September 9, 2020
    Ordered to be Reported (Amended) by Voice Vote.
  • December 7, 2020
    Placed on the Union Calendar, Calendar No. 508.
  • December 7, 2020
    Committee on the Judiciary discharged.
  • December 7, 2020
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-619, Part I.
  • December 9, 2020
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.
  • December 9, 2020
    Considered under suspension of the rules. (consideration: CR H7076-7083)
  • December 9, 2020
    DEBATE - The House proceeded with forty minutes of debate on H.R. 3797.
  • December 9, 2020
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
  • December 9, 2020
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7076-7078)
  • December 9, 2020
    Motion to reconsider laid on the table Agreed to without objection.
  • December 10, 2020
    Received in the Senate.
  • December 18, 2020
    Read twice and referred to the Committee on the Judiciary.
Earl Blumenauer

Earl Blumenauer

Democratic Representative

Oregon

Cosponsors (21)
Chris Stewart (Republican)Barbara Lee (Democratic)Raúl M. Grijalva (Democratic)Lisa Blunt Rochester (Democratic)Andy Harris (Republican)J. Luis Correa (Democratic)Dina Titus (Democratic)John R. Curtis (Republican)Greg Walden (Republican)Debbie Dingell (Democratic)Earl L. "Buddy" Carter (Republican)Rob Bishop (Republican)Lloyd Smucker (Republican)H. Morgan Griffith (Republican)Eleanor Holmes Norton (Democratic)Sean Casten (Democratic)Vicky Hartzler (Republican)Matt Gaetz (Republican)Zoe Lofgren (Democratic)Cathy McMorris Rodgers (Republican)Bryan Steil (Republican)

Crime and Federal Government Surveillance Subcommittee, Judiciary Committee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

Health

Related Bills

  • HR 116-1119: Responsibly Addressing the Marijuana Policy Gap Act of 2019
  • S 116-421: Responsibly Addressing the Marijuana Policy Gap Act of 2019
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresAlternative treatmentsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesFood and Drug Administration (FDA)Health personnelLicensing and registrationsMedical researchResearch administration and funding